The price-to-earnings ratio for Alkermes plc (NASDAQ: ALKS) is 19.59x, which is above its average ratio. Moreover, the 36-month beta value for ALKS is 0.61. Analysts have varying opinions on the stock, with 6 analysts rating it as a “buy,” 0 as “overweight,” 6 as “hold,” and 0 as “sell.”
The average price recommended by analysts for Alkermes plc (ALKS) is $30.97, which is $6.79 above the current market price. The public float for ALKS is 164.11M and currently, short sellers hold a 4.87% of that float. On November 21, 2023, ALKS’s average trading volume was 1.93M shares.
ALKS) stock’s latest price update
Alkermes plc (NASDAQ: ALKS)’s stock price has decreased by -0.25 compared to its previous closing price of 24.24. However, the company has seen a 0.83% increase in its stock price over the last five trading sessions. Zacks Investment Research reported 2023-11-14 that Alkermes’ (ALKS) growth is being driven by the sale of its proprietary products, Vivitrol, Aristada and Lybalvi. However, stiff competition in the target market remains an overhang.
ALKS’s Market Performance
Alkermes plc (ALKS) has seen a 0.83% rise in stock performance for the week, with a -10.51% decline in the past month and a -18.01% plunge in the past quarter. The volatility ratio for the week is 3.84%, and the volatility levels for the past 30 days are at 4.06% for ALKS. The simple moving average for the past 20 days is -0.70% for ALKS’s stock, with a -15.35% simple moving average for the past 200 days.
ALKS Trading at -10.15% from the 50-Day Moving Average
After a stumble in the market that brought ALKS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -28.27% of loss for the given period.
Volatility was left at 4.06%, however, over the last 30 days, the volatility rate increased by 3.84%, as shares sank -1.02% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -18.09% lower at present.
During the last 5 trading sessions, ALKS rose by +0.83%, which changed the moving average for the period of 200-days by -11.59% in comparison to the 20-day moving average, which settled at $24.34. In addition, Alkermes plc saw -7.46% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at ALKS starting from LAURENCIN CATO T, who sale 2,638 shares at the price of $31.85 back on Jun 08. After this action, LAURENCIN CATO T now owns 7,479 shares of Alkermes plc, valued at $84,020 using the latest closing price.
LAURENCIN CATO T, the Director of Alkermes plc, sale 2,800 shares at $31.50 during a trade that took place back on Jun 07, which means that LAURENCIN CATO T is holding 7,479 shares at $88,200 based on the most recent closing price.
Stock Fundamentals for ALKS
Current profitability levels for the company are sitting at:
- -12.80 for the present operating margin
- +76.03 for the gross margin
The net margin for Alkermes plc stands at -14.24. The total capital return value is set at -9.58, while invested capital returns managed to touch -10.79. Equity return is now at value 17.91, with 10.17 for asset returns.
Based on Alkermes plc (ALKS), the company’s capital structure generated 38.21 points at debt to equity in total, while total debt to capital is 27.65. Total debt to assets is 20.31, with long-term debt to equity ratio resting at 36.42. Finally, the long-term debt to capital ratio is 26.35.
When we switch over and look at the enterprise to sales, we see a ratio of 2.41, with the company’s debt to enterprise value settled at 0.10. The receivables turnover for the company is 3.57 and the total asset turnover is 0.56. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.27.
To wrap up, the performance of Alkermes plc (ALKS) has been mixed in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.